A phase I trial of pegylated liposomal doxorubicin (PLD),...

Gynecologic Oncology 2016 / 02 Vol. 140; Iss. 2

A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab and veliparib in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: An NRG Oncology/Gynecologic Oncology Group study

Landrum, Lisa M., Brady, William E., Armstrong, Deborah K., Moore, Kathleen N., DiSilvestro, Paul A., O'Malley, David M., Tenney, Meaghan E., Rose, Peter G., Fracasso, Paula M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
140
Language:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2015.11.024
Date:
February, 2016
File:
PDF, 255 KB
english, 2016
Conversion to is in progress
Conversion to is failed